We are at the dawn of a new era in healthcare.

Our mission is to nurture the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.

We will take a thematic approach and focus on psychedelic medicine companies with clear paths to revenues that can create sustainable shareholder value. We are targeting clinic operators, retreat centres, biopharma companies and the technology sectors. We intend to provide stewardship, scale, access to capital and liquidity.

Our team includes proven experience at creating, scaling and financing businesses within the psychedelic medicine sector. This blend of operational and capital markets expertise provides a unique mix of skills in the identification, acquisition and nurturing of companies in the nascent but expanding sector.

Ultimately we are a group of professionals dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.